XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance at Dec. 31, 2021 $ 767,557 $ (43,693) $ 196,383 $ 59,668 $ (59,668) $ (2,228) $ 513,734 $ 15,975
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 288,016           288,016  
Dividends declared (22,803)           (22,803)  
Other comprehensive income (loss), net of tax 593         593    
Stock repurchases under buyback program (48,749)   (6,771)       (41,978)  
Repurchases of shares for tax payments related to the vesting and exercise of share-based grants (10,036)   (10,036)          
Issuance of shares upon exercise of common stock options 195   195          
Stock-based compensation expense 15,596   15,596          
Ending balance at Sep. 25, 2022 946,676   195,367 0   (1,635) 752,944  
Beginning balance at Jun. 26, 2022 897,590   191,295 0   (1,517) 707,812  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 58,819           58,819  
Dividends declared (7,540)           (7,540)  
Other comprehensive income (loss), net of tax (118)         (118)    
Stock repurchases under buyback program (7,440)   (1,293)       (6,147)  
Repurchases of shares for tax payments related to the vesting and exercise of share-based grants (1)   (1)          
Issuance of shares upon exercise of common stock options 14   14          
Stock-based compensation expense 5,352   5,352          
Ending balance at Sep. 25, 2022 946,676   195,367 0   (1,635) 752,944  
Beginning balance at Dec. 31, 2022 955,169   197,003 0   (695) 758,861  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 112,080           112,080  
Dividends declared (29,927)           (29,927)  
Other comprehensive income (loss), net of tax (109)         (109)    
Stock repurchases under buyback program (12,236)   (1,649)       (10,587)  
Repurchases of shares for tax payments related to the vesting and exercise of share-based grants (8,762)   (8,762)          
Issuance of shares upon exercise of common stock options 1,413   1,413          
Stock-based compensation expense 13,675   13,675          
Ending balance at Oct. 01, 2023 1,031,303   201,680 0   (804) 830,427  
Beginning balance at Jul. 02, 2023 997,422   196,912 0   (794) 801,304  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 39,550           39,550  
Dividends declared (10,021)           (10,021)  
Other comprehensive income (loss), net of tax (10)         (10)    
Stock repurchases under buyback program (460)   (54)       (406)  
Repurchases of shares for tax payments related to the vesting and exercise of share-based grants (1,177)   (1,177)          
Issuance of shares upon exercise of common stock options 270   270          
Stock-based compensation expense 5,729   5,729          
Ending balance at Oct. 01, 2023 $ 1,031,303   $ 201,680 $ 0   $ (804) $ 830,427